Cancer Science · 2005 · 24 citations · 36 references
MedicineGeneticsMolecular GeneticsCancer GeneticsMolecular OncologyNeoplasiaCancer EpigeneticsCancer GenomicsEpigenetic Alterations In CancerAberrant Dna MethylationEpigenetics Of Gastric CancerMolecular Mechanisms Of CarcinogenesisPromoter MethylationPromoter Methylation AnalysisTumor Suppressor Gene AnalysisTumor Suppressor Gene HypermethylationTumor Suppressor Gene Methylation
N-Methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced rat stomach carcinomas are considered to be a good model for differentiated-type human stomach carcinomas. However, as for their molecular basis, only infrequent mutations of Catnb (beta-catenin) and Trp53 (p53) have been observed. Here, we carried out a whole-genome analysis of loss of heterozygosity (LOH) using 21 stomach carcinomas induced by MNNG in F(1) hybrids of ACI and BUF rats, and also analyzed promoter methylation of four tumor-suppressor genes. LOH analysis was performed using 130 polymorphic markers covering rat chromosomes 1-20 with an average interval of 20 Mbp. Despite adapting conditions so that LOH could be detected with up to a 50% contamination of stromal cells, no LOH was detected at any loci. CpG islands in putative promoter regions of four tumor-suppressor genes, Cdh1 (E-cadherin), Cdkn2a (p16), Mlh1, and Rassf1a, were analyzed by methylation-specific polymerase chain reaction (PCR). However, no methylation was detected. In contrast, the promoter region of Pgc (pepsinogen C), which lacks a CpG island, was methylated in all 21-cancer samples. These results indicated that LOH spanning a chromosomal region larger than 30-40 Mbp or silencing of Cdh1, Cdkn2a, Mlh1, and Rassf1a, was not involved in MNNG-induced rat stomach carcinomas. The search for other genes involved in these carcinomas needs to be continued.
36
Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas
Graeme Hodgson, Jeffrey H. Hager, Stas Volik et al. · Nature Genetics · 2001 · 300 citations